MKMamta Kapoor

Mamta Kapoor

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mamta Kapoor has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Beyond the Waiting Room: Patient's Perspectives on the Conversational Nuances of Pre-Consultation Chatbots

    by Brenna Li, Ofek Gross, Noah Crampton, Mamta Kapoor, Saba Tauseef, Mohit Jain, Khai N. Truong, Alex Mariakakis

    Pre-consultation serves as a critical information exchange between healthcare providers and patients, streamlining visits and supporting patient-centered care. Human-led pre-consultations offer many benefits, yet they require significant time and energy from clinical staff. In this work, we identify design goals for pre-consultation chatbots given their potential to carry out human-like conversations and autonomously adapt their line of questioning. We conducted a study with 33 walk-in clinic patients to elicit design considerations for pre-consultation chatbots. Participants were exposed to one of two study conditions: an LLM-powered AI agent and a Wizard-of-Oz agent simulated by medical professionals. Our study found that both conditions were equally well-received and demonstrated comparable conversational capabilities. However, the extent of the follow-up questions and the amount of empathy impacted the chatbot’s perceived thoroughness and sincerity. Patients also highlighted the importance of setting expectations for the chatbot before and after the pre-consultation experience.


  • Open Access

    Patient Perceived Barriers and Enablers to Medication Adherence in the Treatment of Depression: A Qualitative Study

    by Yuki Meng, Christopher Chiu, Mamta Kapoor, Shelly-Anne Li, Navaldeep Kaur, Patricia Marr, Debbie Kwan, Kori Leblanc, Catherine Ji, Christine Papoushek

    Background: Depression affects approximately 280 million individuals globally and it is a leading cause of disability. Despite effective medication options, 50% of patients prematurely discontinue antidepressants within 6 months. We sought to understand patients’ perspectives regarding their needs and expectations related to antidepressants. Objectives: To identify and describe enablers and barriers that influence adult patients’ medication adherence in depression treatment and to explore patients’ educational needs on initiating or continuing antidepressant therapy. Methods: Qualitative descriptive study was conducted using individual, semi-structured interviews of adult patients with depression who were prescribed an antidepressant within 3 months of study recruitment at an urban primary care clinic in Toronto, Canada. Thirteen participants were interviewed. Interviews were recorded and transcribed verbatim for inductive thematic analysis. Results: Six themes emerged: safety and effectiveness of antidepressant, understanding of depression and its management, medication administration, healthcare experiences in the treatment of depression, and social influences and relationships. Barriers to adherence included adverse effects of antidepressants, preference for non-pharmacological therapies, uncertainty about therapeutic effects, and social stigma. In contrast, enablers were positive responses from antidepressants, fear of relapse, reminder aids, established routine, and a trusting patient-provider relationship. Participants desired access to reliable, evidence-based, and personalized educational information delivered through verbal, written, and digital formats to support antidepressant adherence. Conclusion: To overcome the identified barriers, educational strategies should involve both patients and their prescribers to identify patient-specific needs and treatment goals, engage in shared decision-making, and maintain consistent follow-up to support antidepressant adherence.